¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"specific immune suppression"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® immune system ÇÑ±Û ¸é¿ªÃ¼°è
¼³¸í   
  ¼¼Æ÷¼ººÐ ¹× ºÐÀÚ¼ººÐÀÇ º¹ÇÕü°è·Î¼­, ÀÌÀÇ ÀÏÂ÷±â´ÉÀº ÀÚ±â(self)¸¦ ºñÀÚ±â(not self)·ÎºÎÅÍ ±¸º°ÇÏ°í ¿ÜºÎ»ý¹° ¶Ç´Â ¹°Áú¿¡ ´ëÇØ ¹æ¾îÇϴ °ÍÀÌ´Ù. ÀÏÂ÷ÀûÀΠ¼¼Æ÷¼ººÐÀº ¸²ÇÁ±¸¿Í Å«Æ÷½Ä¼¼Æ÷À̸ç ÀÏÂ÷ÀûÀΠºÐÀÚ¼ººÐÀº Ç×ü¿Í ¸²Æ÷Ä«ÀÎÀÌ´Ù.
  
  
¿µ¹® specific gravity ÇÑ±Û ºñÁß
¼³¸í   
  ´ÜÀ§ ºÎÇÇ´ç Áú·®. ¼Òº¯ÀÇ ºñÁßÀº ¼Òº¯ÀÇ ³óµµ¸¦ ¹Ý¿µÇÑ´Ù. ¿¹¸¦ µé¾î ¼Òº¯ÀÇ ºñÁßÀÌ Å©¸é, ÄáÆÏÀÇ ¹°Èí¼ö°¡ ¿øÈ°È÷ ÀÌ·ç¾îÁö°í ÀÖÀ½À» ³ªÅ¸³½´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • burst-suppression
    µ¹¹ßÆÄ¾ïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • motion artifact suppression technique
    ¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
  • suppression
    1. ¾ïÁ¦, ¾ï¾Ð 2. Á¦°Å 3. ÁøÈ­
  • suppression amblyopia
    ¾ïÁ¦¾à½Ã
  • suppression scotoma
    ¾ïÁ¦¾ÏÁ¡
  • water suppression
    ¹°ºÐÀÚ¾ïÁ¦
  • acquired immune deficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • circulating immune complex
    ¼øÈ¯¸é¿ªº¹ÇÕü
  • drug-induced immune complex
    ¾à¹°À¯¹ß¸é¿ªº¹ÇÕü
  • human rabies immune globulin
    »ç¶÷¹ÌÄ£°³º´¸é¿ª±Û·ÎºÒ¸°, »ç¶÷±¤°ßº´¸é¿ª±Û·ÎºÒ¸°
  • immune
    ¸é¿ª-
  • immune adherence
    ¸é¿ªºÎÂø
  • immune adherence hemagglutination
    ¸é¿ªºÎÂøÀûÇ÷±¸ÀÀÁý
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune thrombocytopenic purpura
    ¸é¿ªÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ý
  • suppression
    ¾ïÁ¦
  • platelet-specific antigen
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • specific gravity
    ºñÁß
  • specific phobia
    ƯÁ¤°øÆ÷(Áõ)
  • specific
    ƯÀÌ-, ƯÁ¤-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦
  • suppression amblyopia
    ¾ïÁ¦¾à½Ã
  • burst-suppression
    µ¹¹ßÆÄ¾ïÁ¦
  • central suppression
    Á߽ɾïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • magnetization transfer suppression
    ÀÚ±âÈ­Àü´Þ¾ïÁ¦
  • motion artifact suppression technique
    ¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
  • suppression mutation
    ¾ïÁ¦µ¹¿¬º¯ÀÌ
  • obligatory suppression
    ºÒº¯¾ïÁ¦
  • suppression
    ¾ïÁ¦
  • suppression scotoma
    ¾ïÁ¦¾ÏÁ¡
  • water suppression
    ¹°ºÐÀÚ¾ïÁ¦
  • acquired immune deficiency
    ÈÄõ¸é¿ª°áÇÌ
  • acquired immune deficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • ancillary immune system
    º¸Á¶¸é¿ª°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
  • anti-suppression exercise
    ¾ïÁ¦¹æÁöÈÆ·Ã
  • frequency selective fat suppression technique
    Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
  • glucocorticoid suppression test
    ´çÁúÄÚ¸£Æ¼ÄÚÀ̵å¾ïÁ¦½ÃÇè.
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
  • phenotypic suppression
    Ç¥ÇöÇü ¾ïÁ¦
  • SDA= specific dynamic action
    ƯÀ̵¿Àû ÀÛ¿ë.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • antigen, species-specific
    Á¾Æ¯ÀÌÇ׿ø
  • antigen, tumor-specific
    Á¾¾çƯÀÌÇ׿ø
  • antigen, tumor-specific transplantation
    Á¾¾çƯÀÌ À̽ÄÇ׿ø
  • antigen,tumor-specific transplantation
    Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
  • granulocyte-specific antigens
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • group specific C carbohydrate
    ±ºÆ¯ÀÌ C´Ù´çü.
  • group-specific
    ±ºÆ¯ÀÌÀÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
  • anti-suppression exercise
    ¾ïÁ¦¹æÁöÈÆ·Ã
  • burst suppression
    °¨Á¤¾ï¾Ð
  • central suppression
    Á߽ɾïÁ¦
  • deoxyuridine suppression test
    µ¥¿Á½Ã¿ì¸®µò¾ïÁ¦½ÃÇè
  • dexamethasone suppression test
    µ¦»ç¸ÞŸÁ¸¾ïÁ¦½ÃÇè
  • dust suppression
    ¸ÕÁö¹ß»ý¾ïÁ¦.
  • facultative suppression
    ÀӽþïÁ¦
  • fat suppression
    Áö¹æ ¾ïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
  • glucocorticoid suppression test
    ´çÁúÄÚ¸£Æ¼ÄÚÀ̵å¾ïÁ¦½ÃÇè.
  • magnetization transfer suppression
    ÀÚÈ­ Àü´Þ ¾ïÁ¦
  • motion artifact suppression technique
    ¿îµ¿ Àΰø À½¿µ ¾ïÁ¦¼ú
  • obligatory suppression
    ºÒº¯¾ïÁ¦
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Immune cause (Hemolytic anemia)
    ¸é¿ª¿øÀÎ(¿ëÇ÷¼ººóÇ÷)
    [¿¾ ¿ë¾î] ¸é¿ª¼º¿øÀÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specific parasite
    ƯÀ̱â»ýÃæ
  • stage-specific protein
    ¹ßÀ°´Ü°èƯÀ̴ܹéÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specific immune suppression
    ƯÀÌ ¸é¿ª¾ï¾Ð(÷åì¶Øóæ¹åääâ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • allotype suppression
    µ¿Á¾ÀÌÇü¾ï¾Ð(ÔÒðúì¶úþåääâ)
  • external suppression
    ¿ÜºÎ ¾ï¾Ð(èâÝ»åääâ)
  • extracistronic suppression
    ½Ã½ºÆ®·Ð¿Ü(èâ) ¾ï¾Ð(åääâ)
  • extragenic suppression
    ¿Ü·¡ ¾ï¾Ð (èâÕÎåääâ)
  • frameshift suppression
    ƲÀ̵¿(ì¹ÔÑ) ¾ï¾Ð(åääâ)
  • idiotype suppression
    °³Ã¼Æ¯ÀÌÇü ¾ï¾Ð(ËÁô÷÷åì¶úþåääâ)
  • immunological suppression
    ¸é¿ª ¾ï¾Ð(Øóæ¹åääâ)
  • intergenic suppression
    À¯ÀüÀÚ°£ ¾ï¾Ð(ë¶îîí­Êàåääâ)
  • intracistronic suppression
    ½Ã½ºÆ®·Ð³»(Ò®) ¾ï¾Ð(åääâ)
  • intragenic suppression
    À¯ÀüÀÚ³» ¾ï¾Ð(ë¶îîí­Ò®åääâ)
  • intragenic suppression mutation
    À¯ÀüÀÚ³» ¾ï¾Ðº¯ÀÌ(ë¶îîí­Ò®åääâܨì¶)
  • missense suppression
    ¿ÀÀξï¾Ð(è¦ìãåääâ)
  • nonsense suppression
    ³Í¼¾½º ¾ï¾Ð(åääâ)
  • ochre suppression
    ¿À¿ìÄ¿¾ï¾Ð(åääâ)
  • opal suppression
    ¿ÀÆÈ ¾ï¾Ð(åääâ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune
    ¸é¿ª¼ºÀÇ
  • specific absorption rate [=SAR]
    ƯÀÌÈí¼öÀ²
  • specific inflammation
    ƯÀ̼º¿°Áõ
  • fat suppression
    Áö¹æ¾ïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö¼±Åà Áö¹æ¾ïÁ¦(±â)¹ý
  • magnetization transfer suppression
    ÀÚÈ­Àü´Þ¾ïÁ¦
  • motion artifact suppression technique
    ¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
  • phase evolution of fat suppression
    À§»ó¼±È¸ Áö¹æ¾ïÁ¦
  • suppression
    ¾ïÁ¦, ¾ï¾Ð
  • water suppression
    ¹°ºÐÀÚ¾ïÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DST   1) Donor Specific Transfusion
  2) Dexamethasone Suppression Test
DST desensitization test; dexamethasone suppression test; dihydrostreptomycin; disproportionate septal t...
SDS same day surgery; school dental services; self-rating depression scale; sensory deprivation syndrome...
CAST calpastatin; Cardiac Arrhythmia Suppression Trial; Children of Alcoholism Screening Test
HTS head traumatic syndrome; HeLa tumor suppression; human thyroid-stimulating hormone, human thyroid st...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IS Immune suppression
CAST Cardiac Arrhythmia Suppression Trial
CISS Chromosomal in situ suppression
CSD Conditioned Suppression of Drinking
DSI Depolarisation-induced suppression of inhibition
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • allotype suppression
    ¾Ë·Î ŸÀÔ ¾ïÁ¦
    ÀÓ½ÅÁßÀÎ ¸ðü ¾È¿¡ ºÎÄ£ÀÇ alloty
  • bone marrow suppression
    °ñ¼ö ¾ïÁ¦
  • central suppression
    ÁßÃß¼º ¾ïÁ¦, Á᫐ ¾ïÁ¦
  • dexamethasone suppression test
    µ¦»ç¸ÞŸ¼Õ ¾ïÁ¦ Å×½ºÆ®, µ¦»ç¸ÞŸ¼Õ ¾ï¾Ð ½ÃÇè, µ¦»ç¸ÞŸ¼Õ ¾ïÁ¦ °Ë»ç
  • dust suppression
    ¸ÕÁö ¹ß»ý ¾ïÁ¦
  • fat suppression
    Áö¹æ ¾ïÁ¦
  • frequency selective fat suppression technique
    ÁÖÆÄ ¼ö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý, Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý
  • motion artifact suppression technique
    ¿îµ¿ Àΰø À½¿µ ¾ïÁ¦¼ú
  • suppression amblyopia
    ¾ïÁ¦ ¾à½Ã
  • thyroid suppression test
    °©»ó¼± ¾ï¾Ð ½ÃÇè
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº
    1. ÇöÀúÇÑ ¸é¿ª °áÇ̰ú ÇÔ²² ±âȸ°¨¿°, ¼Ó¹ß¼º ¾Ï ¹× ½Å°æ°è Áõ¼¼°¡ µ¿¹Ý. ¹ÙÀÌ·¯½º ÀÚü¿¡ ÀÇÇÑ º´º¯°ú ¸é¿ª´É·Â ÀúÇÏ¿¡ µû¸¥ ±âȸ °¨¿° µîÀÇ ÀÌÂ÷Àû º´º¯ÀÇ µÎ °¡Áö·Î ´ëº°. HIV¿¡ ÀÇÇØ ¹ß»ýµÇ´Â ÁúȯÀ¸·Î ½Å°æ°è°¡ Áß¿ä Ç¥ÀûÁß Çϳª. ¹ÙÀÌ·¯½º¿¡ °¨¿°µÈ »ç¶÷ÀÇ 40% Á¤µµ°¡ Áúº´ÀÌ ¹ß»ý. ¹ÙÀÌ·¯½ºÀÇ Á÷Á¢ÀûÀÎ ¿µÇâ¿¡ ÀÌÇÑ º´º¯À¸·Î´Â ¸²ÇÁ±¸¼º ¼ö¸·¿°°ú HIV ³ú¿° µîÀÌ ÀÖÀ½. 2. ÈÄõ¼º ¸é¿ª°áÇÌÁõ. Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • drug-induced immune complex
    ¾àÁ¦ À¯¹ß¼º ¸é¿ª º¹ÇÕü
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • human rabies immune globulin
    ±¤°ßº´ ¸é¿ª ±Û·ÎºÒ¸°
    °³¿¡°Ô ¹°¸° ÈÄ ±ÕÀÇ ÁøÇàÀ» ¸·±â À§ÇØ Åõ¿©ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
immune suppression Suppression of the immune response by some compound or agent.
(05 Mar 2000)
specific immune globulin Globulin fraction of pooled serums (or plasma) selected for high titre of antibodies specific for a particular antigen, or from persons specifically immunised.
(05 Mar 2000)
site-specific DNA-methyltransferase (adenine-specific) <enzyme> An enzyme responsible for producing a species-characteristic methylation pattern on adenine residues in a specific short base sequence in the host cell DNA. The enzyme catalyses the methylation of DNA adenine in the presence of s-adenosyl-l-methionine to form DNA containing 6-methylaminopurine and s-adenosyl-l-homocysteine.
Registry number: EC 2.1.1.72
(12 Dec 1998)
site-specific DNA methyltransferase (cytosine-specific) <enzyme> An enzyme responsible for producing a species-characteristic methylation pattern on cytosine residues in a specific short base sequence in the host cell's DNA. The enzyme catalyses the methylation of DNA cytosine in the presence of s-adenosyl-l-methionine to form s-adenosyl-l-homocysteine and DNA containing 5-methylcytosine.
Registry number: EC 2.1.1.73
(12 Dec 1998)
ACTH suppression test <investigation> A test that measures the response of the adrenal glands to ACTH.
In this case, dexamethasone is given to the patient and then blood cortisol levels are measured. Under normal conditions, cortisol levels should drop in response to dexamethasone.
In this test one milligram of dexamethasone is administered in the morning and then the blood is drawn for analysis the following morning.
Abnormal test results can indicate Cushing's syndrome.
(27 Sep 1997)
bone marrow suppression <oncology, pharmacology> A side effect of many anticancer and antiviral drugs, including AZT.
Bone marrow suppression leads to a decrease in white blood cells, red blood cells and platelets. Such reductions in turn result in anaemia, bacterial infections and spontaneous or excess bleeding.
(09 Oct 1997)
growth hormone suppression test <investigation> A test to determine if growth hormone is suppressed by hyperglycaemia. Growth hormone blood levels are determined sequentially after ingestion of a glucose-rich meal. If growth hormone levels remain elevated (after the glucose is given) then acromegaly or gigantism is suspected.
(27 Sep 1997)
cortisol suppression test <investigation> A test that measures the response of the adrenal glands to ACTH. In this case, dexamethasone is given to the patient and then blood cortisol levels are measured. Under normal conditions, cortisol levels should drop in response to dexamethasone. In this test one milligram of dexamethasone is administered in the morning and then the blood is drawn for analysis the following morning. Abnormal test results can indicate Cushing's syndrome.
(27 Sep 1997)
nonsense suppression Mutant tRNAs that read a chain termination codon as the signal for incorporation of a specific amino acid residue.
(05 Mar 2000)
suppression 1. The act of suppressing, or the state of being suppressed; repression; as, the suppression of a riot, insurrection, or tumult; the suppression of truth, of reports, of evidence, and the like.
2. <medicine> Complete stoppage of a natural secretion or excretion; as, suppression of urine; used in contradiction to retention, which signifies that the secretion or excretion is retained without expulsion.
3. Omission; as, the suppression of a word.
Synonym: Overthrow, destruction, concealment, repression, detention, retention, obstruction.
Origin: L. Suppressio: cf. F. Suppression.
Source: Websters Dictionary
(01 Mar 1998)
suppression amblyopia The suppression of the central vision in one eye when the images from the two eyes are so different that they cannot be fused into one. This may be due to: 1) faulty image formation (sensory amblyopia); 2) a large difference in refraction between the two eyes (anisometropic amblyopia); or 3) the two eyes pointing in different directions (strabismic amblyopia). Most suppression amblyopia can be reversed if appropriately treated before age 6 years.
Synonym: amblyopia ex anopsia.
(05 Mar 2000)
suppression, genetic The restoration of the wild-type phenotype in an organism possessing a mutationally altered genotype. The effects of the mutation may be suppressed by a second "suppressor" mutation on a different gene, by a suppressor mutation on the same gene but located at a distance from the site of the primary mutation, or by the presence of a cytoplasmic suppressor due to a change in non-chromosomal DNA.
(12 Dec 1998)
dexamethasone suppression test <endocrinology, investigation> A test that measures the response of the adrenal glands to ACTH.
Dexamethasone is given to the patient and then blood cortisol levels are measured. Under normal conditions, cortisol levels should drop in response to dexamethasone. In this test one milligram of dexamethasone is administered in the morning and then the blood is drawn for analysis the following morning.
Abnormal test results can indicate Cushing's syndrome.
(27 Sep 1997)
intergenic suppression The situation where a primary gene and the gene that suppresses it do not lie in the same chromosomal locus.
Compare: intragenic suppression.
(18 Nov 1997)
intragenic suppression <molecular biology> The situation where a primary gene and the mutated gene that suppresses it lie within the same locus.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppression
    ¾ï¾Ð
  • suppression
    ¾ïÁ¦;Áø¾Ð;¹ß¸Å ±ÝÁö;»èÁ¦
  • specific
    ƯÁ¤ÇÑ,Ưº°ÇÑ
  • specific
    Ư¼öÇÑ;µ¶Æ¯ÇÑ;¸íÈ®ÇÑ;Á¾ÀÇ;Ưȿ ÀÖ´Â
  • specific duty
    Á¾·®¼¼
  • specific gravity
    ºñÁß
  • specific heat
    ºñ¿­
  • immune
    ¸é¿ªÀÇ
  • immune
    ¸é¿ªÀÇ;(Àü¿°º´,º´µ¶µîÀ»)¸éÇÑ;¸é¿ª¼ºÀÇ(to,from);(°ú¼¼,°ø°Ý µî¿¡¼­);¸éÁ¦µÈ(exempt);(..À») ´çÇÒ ¿°·Á°¡ ¾ø´Â(from,against);(¿¡)µ¿ÇÏÁö ¾Ê´Â;¿µÇâÀ» ¹ÞÁö ¾Ê´Â(to);¸é¿ª(¸éÁ¦)ÀÚ
  • immune body
    ¸é¿ªÃ¼;Ç×ü(antibody)
  • immune complex
    ¸é¿ª º¹ÇÕü
  • immune response
    ¸é¿ª ÀÀ´ä;¸é¿ª ¹ÝÀÀ
  • immune serum
    ¸é¿ª Ç÷û
  • immune surveillance
    IMMUNOLOGICAL SURVEILLANCE
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á